European Commission Approves Nippon Steel Acquisition of US Steel-March 2024-www.financetom.com

European Commission Approves Nippon Steel Acquisition of US Steel

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

European Commission Approves Nippon Steel Acquisition of US Steel

May 6, 2024 12:06 PM

02:38 PM EDT, 05/06/2024 (MT Newswires) -- The European Commission has approved the acquisition of United States Steel ( X ) by Nippon Steel Corp. of Japan.

The commission said it concluded that the transaction would not raise competition concerns.

Price: 37.68, Change: +1.21, Percent Change: +3.32

Previous page： Senegal's Petrosen expects final investment decision on gas project in 2025 Next page： Endeavour Silver Swings to Q3 Profit, Revenue Rises

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Senegal's Petrosen expects final investment decision on gas project in 2025

Nov 5, 2024

CAPE TOWN, Nov 5 (Reuters) - Senegal's national oil company Petrosen expects a final investment decision (FID) on the Yakaar-Teranga gas project in 2025, its director general said on Tuesday. Yes, our objective is to have this FID by mid-2025 if everything is going OK, Thierno Ly said. Petrosen is partnering with Kosmos Energy ( KOS ) to develop the...

Endeavour Silver Swings to Q3 Profit, Revenue Rises

Nov 5, 2024

09:30 AM EST, 11/05/2024 (MT Newswires) -- Endeavour Silver ( EXK ) reported Q3 adjusted net earnings Tuesday of $0.01 per share, swinging from a loss of $0.04 a year earlier. Two analysts polled by Capital IQ expected a breakeven figure. Revenue for the quarter ended Sept. 30 was $53.4 million, up from $49.5 million a year earlier. Two analysts...

Why Bionomics (BNOX) Stock Is Up 100% Today

Nov 5, 2024

Bionomics Ltd ( BNOX ) – ADR shares are trading higher by 177% to 53 cents Tuesday morning after the company announced it received a milestone payment of AUD$1 million from Carina Biotech related to their partnered oncology program, BNC101. What To Know: This payment aligns with their 2020 exclusive license agreement for BNC101, a monoclonal antibody targeting LGR5, a...

Hims & Hers Health to Offer Generic Diabetes Drug in 2025

Nov 5, 2024

07:37 AM EST, 11/05/2024 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Monday in a letter to shareholders it plans to launch diabetes drug Liraglutide on its platform in 2025. The company said it has already confirmed a core supplier for the drug, which is a generic version of Novo Nordisk's (NVO) type-2 diabetes treatment Victoza, and...